NCT01400113View on ClinicalTrials.gov

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Agitation

Interventions

DRUG

Asenapine

Asenapine Sublingual Tablet 10mg, single-dose

DRUG

Placebo

Placebo Sublingual Tablet, single-dose

Trial Locations (1)

13203

St. Joseph's Hospital Health Center-Comprehensive Psychiatric Emergency Program (CPEP), Syracuse

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

Unity Health Toronto

OTHER